Search results
1 gru 2020 · Studies evaluating 5-year survival of vaginal melanoma have reported rates ranging from 13% to 32.3% [20,82,106,107]. AJCC stage [ 108 ], lymph node status [ 81 , 106 ], tumor size [ 60 ], and primary treatment [ 81 , 82 ] are the major prognostic predictors of vaginal melanoma.
30 cze 2021 · The main treatment for both vulvar and vaginal melanoma is surgical excision of the tumor. Clinical experience in the last few decades has shown no significant differences in survival rates between radical excision and limited excisions with safety margins (Table 5), so limited resections are currently recommended [32,103].
14 cze 2021 · While the mortality rate of cutaneous melanoma has dropped by 7% annually during the last 5 years, the prognosis of vulvar melanoma remains dismal: the 5-year overall survival rate is 47% compared with 92% for cutaneous melanoma.
1 paź 2024 · Survival in vulvar melanoma is superior to that of vaginal melanoma. •. Most patients disease free five years after surgical resection received an adjuvant therapy. •. Complete response to treatment of recurrence or progression was most frequent with nivolumab plus ipilimumab. •.
15 maj 2014 · The average age at presentation for vulvar melanomas is approximately 60, with reported means and medians ranging from ages 54 to 68. 1 - 4 The range of ages at presentation is wide, with cases reported in girls as young as age 10 and women as old as age 99. 1 The average age of presentation for vaginal melanomas is similar, but without a range ...
1 paź 2023 · The 5-year overall survival for vulvovaginal melanoma is 60%. •. The 5-year local progression free survival for vulvovaginal melanoma is 63%. •. Preinvasive disease at the surgical margins may play an important role in local recurrence. •. Patients with early disease (Stage 0) and advanced Stage (III) rarely recur locally. Abstract. Objectives.
20 wrz 2020 · Objective: Melanoma comprises 5% to 10% of vulvar cancers and prognosis is poor. The purpose of this study was to identify prognostic factors and treatment patterns for vulvar melanoma using the National Cancer Database (NCDB). Methods: The NCDB was queried for patients with invasive vulvar melanoma from 2004-2015.
